PCVX

PCVX

USD

Vaxcyte Inc. Common Stock

$34.460-0.670 (-1.907%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$35.130

High

$35.390

Low

$34.260

Volume

1.06M

Company Fundamentals

Market Cap

4.4B

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

2.50M

Exchange

NMS

Currency

USD

52-Week Range

Low $27.66Current $34.460High $121.055

Related News

GlobeNewswire

Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update

-- Company Reported Positive Topline Safety, Tolerability and Immunogenicity Data from Phase 2 Dose-Finding Study of VAX-24 in Healthy Infants; Balance of Data Expected by End of 2025 -- -- Initiated Second and Final

View more
Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

SAN CARLOS, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (NASDAQ:PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today

View more
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
Analyst Upgrades

Cantor Fitzgerald Initiates Coverage On Vaxcyte with Overweight Rating

Cantor Fitzgerald analyst Carter Gould initiates coverage on Vaxcyte with a Overweight rating.

View more
Cantor Fitzgerald Initiates Coverage On Vaxcyte with Overweight Rating